COMMUNIQUÉS West-GlobeNewswire

Poseida Announces Initial Phase 1 Data for P-BCMA-101 CAR-T Stem Cell Memory Product in Patients with Relapsed/Refractory Multiple Myeloma
17/04/2018
Low dose cohort completed with rapid and clear signs of efficacy in all three patients, and no cytokine release syndrome Data presented at the American Association for Cancer Research (AACR) Annual Meeting 2018 SAN [...]
Biomerica Announces Third Quarter Financial Results
17/04/2018
IRVINE, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA ) today reported net sales of $4,433,785 for the nine months ending February 28, 2018, compared to $4,342,247 for the period ended [...]
Maple Leaf Green World Inc. Receives Final Approval to List on the NEO Exchange and Delist Common Shares from the TSXV
17/04/2018
CALGARY, Alberta, April 17, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (TSXV:MGW) (OTCQB:MGWFF) announces that, further to the Company’s press release dated February 27, [...]
Sarah Boyce Joins Akcea Therapeutics as President and Member of the Board of Directors
17/04/2018
CAMBRIDGE, Mass., April 17, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., today announced that, following today’s close of the transaction licensing [...]
Akcea and Ionis Complete Licensing Transaction to Commercialize Inotersen for hATTR
17/04/2018
Akcea shareholders approved the transaction on April 16 at a Special Meeting of Stockholders Ionis licenses Akcea worldwide rights to inotersen and AKCEA-TTR-L Rx CAMBRIDGE, Mass. and CARLSBAD, Calif., April 17, 2018 ( [...]
NSS Labs Announces 2018 Advanced Endpoint Protection Group Test Results
17/04/2018
11 products receive Recommended Rating ; 4 products receive Security Recommended Rating; 1 product receives Neutral rating; and 5 products receive Caution Rating AUSTIN, Texas, April 17, 2018 (GLOBE NEWSWIRE) -- NSS [...]
Oncobiologics Appoints Randy Thurman to Board of Directors
17/04/2018
CRANBURY, N.J., April 17, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ: ONS ) today announced the appointment of Randy Thurman to its board of directors, effective April 13, 2018. At the same time, Oncobiologics [...]
Cyclacel’s CYC065 CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic Lymphocytic Leukemia
17/04/2018
Suppression of both BCl-2 and Mcl-1 anti-apoptotic proteins is a novel strategy in CLL BERKELEY HEIGHTS, N.J., April 17, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) (" [...]
Resverlogix Announces Proposed Offering of Units
17/04/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, April 17, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX ) [...]
Hemispherx Successfully Completes Production of More Than 8,500 Vials of Ampligen for Commercial Sales and Expanded Clinical Programs
17/04/2018
ORLANDO, Fla., April 17, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology, is pleased [...]
HMS Holdings Corp. To Report First Quarter 2018 Financial and Operating Results
17/04/2018
IRVING, Texas, April 17, 2018 (GLOBE NEWSWIRE) -- HMS Holdings Corp. (NASDAQ: HMSY ) today announced it will report first quarter 2018 financial and operating results at 7:30 am CT / 8:30 am ET on Friday, May 4, 2018. [...]
Agritek Holdings Inc. Applauds New Deal With President Trump And Senator Cory Gardner Clearing Way For Colorado Medical And Recreational Cannabis Laws Including New Agritek Operations
17/04/2018
LOS ANGELES, CA, April 17, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]
Cesca Therapeutics Announces First Evaluation Agreement With a Leading U.S. Academic Research Institution for X-Series™ Products That Provide Automated, Closed System Cellular Processing
17/04/2018
RANCHO CORDOVA, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that [...]
Scythian Biosciences Appoints Gabriel Meneses as Vice President of Latin America and Caribbean
17/04/2018
Global Business Development Expert Roberto Pérez Ruiz Joins Company’s Senior Team TORONTO, April 17, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) ( [...]
Oxford Immunotec Schedules First Quarter 2018 Earnings Release and Conference Call for May 1, 2018
17/04/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., April 17, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced that it plans to release first [...]
Extendicare Completes $110 million Offering of 5.00% Convertible Debentures
17/04/2018
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES MARKHAM, Ontario, April 17, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced today the [...]
GTX Corp SmartSoles Showcased at the Innovation & Style 2018 Fair in Munich
17/04/2018
LOS ANGELES, April 17, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO ) , an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive technology business, announced that [...]
Wave Life Sciences to Present Data on ALS and FTD Programs and on Huntington's Disease at the 2018 American Academy of Neurology Annual Meeting
17/04/2018
CAMBRIDGE, Mass., April 17, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE ), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined [...]
VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients
17/04/2018
Independent Data and Safety Monitoring Board (DSMB) unanimously recommends continuation of study without modification Low-dose study arm: enrollment complete Intermediate-dose study arm: enrollment commenced CAMBRIDGE, [...]

Pages